Dr. Martens (LON:DOCS) Trading Up 7.2% – What’s Next?

Dr. Martens plc (LON:DOCS) shares traded up 7.2% during mid-day trading on Tuesday . The company traded as high as GBX 71.30 and last traded at GBX 68.90. 1,553,801 shares were traded during trading, a decline of 84% from the average session volume of 9,968,290 shares. The stock had previously closed at GBX 64.30.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Berenberg Bank reaffirmed a “buy” rating and set a GBX 114 price target on shares of Dr. Martens in a research report on Wednesday, May 6th. Royal Bank Of Canada restated a “sector perform” rating on shares of Dr. Martens in a report on Tuesday, February 3rd. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 114.

Dr. Martens Stock Up 8.1%

The company has a quick ratio of 1.13, a current ratio of 2.18 and a debt-to-equity ratio of 120.66. The company has a market capitalization of £672.59 million, a price-to-earnings ratio of 40.91, a P/E/G ratio of 6.40 and a beta of 0.22. The stock’s fifty day moving average price is GBX 63.94 and its 200-day moving average price is GBX 71.49.

Insider Activity

In other news, insider Ije Nwokori sold 204,051 shares of Dr. Martens stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of GBX 66, for a total value of £134,673.66. Insiders have purchased 930 shares of company stock valued at $59,984 in the last 90 days. 2.81% of the stock is owned by company insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.